CreativeOne Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CreativeOne Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,388	Closed	-$535K	–	1271
2025 Q4	$535K	Buy	+4,388	New	+$503K	0.01%	769
2023 Q3	–	Sell	-14,276	Closed	-$1.19M	–	837
2023 Q2	$1.19M	Buy	+14,276	New	+$1.19M	0.06%	297
2021 Q4	–	Sell	-13,074	Closed	-$1.64M	–	800
2021 Q3	$1.64M	Sell	13,074 -29,338	-69%	-$3.78M	0.1%	182
2021 Q2	$5.74M	Buy	42,412 +716	+2%	+$94.1K	0.35%	60
2021 Q1	$5.66M	Buy	41,696 +10,229	+33%	+$1.53M	0.43%	46
2020 Q4	$4.43M	Buy	31,467 +5,383	+21%	+$689K	0.37%	54
2020 Q3	$2.91M	Buy	26,084 +8,743	+50%	+$980K	0.4%	45
2020 Q2	$1.94M	Buy	17,341 +2,824	+19%	+$278K	0.3%	57
2020 Q1	$1.12M	Buy	14,517 +5,972	+70%	+$529K	0.21%	63
2019 Q4	$813K	Buy	8,545 +4,810	+129%	+$416K	0.14%	81
2019 Q3	$285K	Buy	3,735 +1,281	+52%	+$106K	0.06%	143
2019 Q2	$215K	Buy	+2,454	New	+$209K	0.05%	166

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CreativeOne Wealth's XBI Position: Q1 2026 in Review

CreativeOne Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 4,388 shares — an estimated $535K sold.

CreativeOne Wealth first reported a position in XBI in Q2 2019 and held it in 12 quarters. The position peaked at $5.74M in Q2 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

CreativeOne Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
CreativeOne Wealth sold 4,388 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $535K.
CreativeOne Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and held it in 12 quarters.
CreativeOne Wealth's State Street SPDR S&P Biotech ETF position peaked at $5.74M in Q2 2021.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.